Back
Novavax Vs. Viking Therapeutics Industry Stock Comparison
Sell
44
NVAX
Novavax
Last Price:
14.25
Seasonality Move:
14.68%
Sell
38
VKTX
Viking Therapeutics
Last Price:
50.50
Seasonality Move:
-3.44%
Sell
44
Novavax (NVAX)
is a Sell
Is Novavax a Buy, Sell or Hold?
- The current Novavax [NVAX] share price is $15.06. The Score for NVAX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- NVAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $52.10. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVAX Stock Price Chart
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $52.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
NVAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.99 | Buy |
| Relative Strength Index (14 RSI): | 53.21 | Buy |
| Chaikin Money Flow: | -6445359 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.84 - 18.2) | Buy |
| Bollinger Bands (100): | (2.31 - 11.99) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.62 | Sell |
| Relative Strength Index (14 RSI): | 31.38 | Sell |
| Chaikin Money Flow: | 45869 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.87 - 71.09) | Sell |
| Bollinger Bands (100): | (40.62 - 80.36) | Sell |
NVAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.51 | Sell |
| 20-day SMA: | 16.13 | Sell |
| 50-day SMA: | 9.66 | Buy |
| 200-day SMA: | 6.73 | Buy |
| 8-day EMA: | 16.52 | Sell |
| 20-day EMA: | 15.27 | Sell |
| 50-day EMA: | 11.54 | Buy |
| 200-day EMA: | 8.69 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.97 | Sell |
| 20-day SMA: | 60.52 | Sell |
| 50-day SMA: | 67.71 | Sell |
| 200-day SMA: | 37.37 | Buy |
| 8-day EMA: | 55.23 | Sell |
| 20-day EMA: | 60.09 | Sell |
| 50-day EMA: | 63.57 | Sell |
| 200-day EMA: | 45.15 | Buy |
Novavax Earnings Growth & NVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.20 per share, and a decrease next year of $0.85 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.
Novavax Technical Analysis
| May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||